Dr. GPCR Podcast

About Murat Tunaboylu

"Murat Tunaboylu, Antiverse's CEO, has a software engineering and bioinformatics background. Mid-career, he has worked in finance and developed high-frequency trading systems. After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer research and automated Thermo Fisher Scientific’s gene synthesis workflows. He has co-founded consultancy and biotech companies Svarlight and Antiverse. His current focus is to realise Antiverse’s mission: engineering the future of drug discovery."

Murat Tunaboylu on the web

• Antiverse

• DSV

• Future of Drug Discovery Podcast

• Twist Bioscience

• LinkedIn

• Twitter

• Dr. GPCR

About Ben Holland

"Ben gained his masters in Engineering Science from Oxford, taking a specialisation in information engineering. Following this, he joined an early-stage medical device start-up and in 5 years was responsible for project R&D and managing a focused development team, pursued international strategic partnerships, managed IP matters, helped establish a manufacturing line in Malaysia and is named as inventor on several patents. He then returned to information engineering and has been working in machine learning for nearly 10 years, applying it to antibody generation, analysis, and property prediction since 2017"

Ben Holland on the web

• Antiverse

• The Antibody Society YT

• LinkedIn

• Twitter

• Dr. GPCR